Lirum Therapeutics (Lirum Therapeutics) Purchase Of Property, Plant, Equipment : $0.00 Mil (TTM As of Dec. 2023)

View and export this data going back to 2024. Start your Free Trial

What is Lirum Therapeutics Purchase Of Property, Plant, Equipment?

Lirum Therapeutics's purchase of property, plant, equipment for the three months ended in Dec. 2023 was $0.00 Mil. It means Lirum Therapeutics spent $0.00 Mil on purchasing property, plant, equipment. Lirum Therapeutics's purchase of property, plant, equipment for the trailing twelve months (TTM) ended in Dec. 2023 was $0.00Mil.

Compared with last quarter ($0.00 Mil in Sep. 2023 ), Lirum Therapeutics spent the same money on purchasing property, plant, equipment in Dec. 2023 ($0.00 Mil).

Lirum Therapeutics Purchase Of Property, Plant, Equipment Historical Data

The historical data trend for Lirum Therapeutics's Purchase Of Property, Plant, Equipment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lirum Therapeutics Purchase Of Property, Plant, Equipment Chart

Lirum Therapeutics Annual Data

Trend

Dec21

Dec22

Dec23

Purchase Of Property, Plant, Equipment

Lirum Therapeutics Quarterly Data
	Dec21	Sep22	Dec22	Sep23	Dec23
Purchase Of Property, Plant, Equipment	-	-	-	-	-

Lirum Therapeutics Purchase Of Property, Plant, Equipment Calculation

The amount used to purchase PPE.

Purchase Of Property, Plant, Equipment for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

Lirum Therapeutics Purchase Of Property, Plant, Equipment Related Terms

Thank you for viewing the detailed overview of Lirum Therapeutics's Purchase Of Property, Plant, Equipment provided by GuruFocus.com. Please click on the following links to see related term pages.

Lirum Therapeutics (Lirum Therapeutics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Lirum Therapeutics Inc (NAS:LRTX) » Definitions » Purchase Of Property, Plant, Equipment

Comparable Companies

Traded in Other Exchanges

N/A

Address

590 Madison Avenue, 21st Floor, New York, NY, USA, 10022

Website

https://www.lirumtx.com

Lirum Therapeutics Inc is clinical-stage biopharmaceutical company focused on the treatment of debilitating diseases through the acquisition, development, and commercialization of novel drug candidates with compelling mechanisms of action, regulatory pathways, and commercial opportunities. Its product candidate, LX-101, formerly 765IGF-MTX, is a novel, clinical-stage, "next generation," precision-engineered targeted therapy directed to the IGF-1R.

Lirum Therapeutics (Lirum Therapeutics) Headlines

No Headlines